by DMG & PARTNERS SECURITIES (3 Dec)
IN November, the Chinese government overhauled the entire dairy industry to improve safety at every step of the value chain. From cow breeding to the end product that customers consume.
We believe that China Milk is going to benefit from this because they have extremely high quality standards and supervision at every stage of the value chain.
China Milk feeds its herd the best quality feed, which it grows itself. The fertiliser used to grow the animal feed is also from its own herd. This insures that there are no dangerous chemicals being added to the crops. In our view, we believe that the Chinese government should base quality standards using China Milk as an example.
The exposure of many problems existing in quality control and supervision of the industry has dampened China's global reputation. However, we believe that the rebuilding process of its dairy industry will only make China's dairy sector more attractive in the long term.
-Research Report by DMG & PARTNERS SECURITIES (3 Dec)
Showing posts with label China Milk. Show all posts
Showing posts with label China Milk. Show all posts
Thursday, December 4, 2008
Thursday, November 20, 2008
Singapore Strategy
by DMG & Partners Securities (19 Nov)
TARGETING survivors: Some corporates may not have banks' support through this rough patch. The market remains concerned about the impact of global economic deterioration on corporate earnings.
Investors are closely scrutinising companies that have overstretched via massive borrowings to fund their growth, or have yet to generate sufficient operating cash flow, as these corporates are at the highest risk of breaching bank covenants if business conditions worsen further.
On the other hand, there are corporates whose balance sheets are strong. Even with the deterioration in business conditions, banks will continue to support these corporates for their working capital and capital expenditure needs.
These are the companies that are seen to survive this downturn. When economic conditions eventually improve, these companies could return to similar levels of profit or even exceed their previous peak profit levels.
Over the past few weeks, we have reviewed the financial forecasts and TPs for all the stocks under our coverage. With the cuts in TPs, we now arrive at a fair Straits Times Index (STI) target of 2,080 over the next 12 months.
However, in the short term, we see further weakness which could bring the STI to as low as 0.95 times P/B, or a 1,560 level. With the downside of about 10 per cent from the current STI level and difficulty in pinpointing the exact bottom, we recommend investors to start nibbling at stocks that will survive this crisis.
We have identified the following big-cap stocks which we believe will ride through the crisis and emerge stronger:
CapitaLand ('buy', TP: $3.05): At current levels, CapitaLand is trading at a 24.4 per cent discount to its end-Q3 2008 NAV of $3.60. During past crises, CapitaLand has been trading at 40-60 per cent discount to NAV. Taking the view that CapitaLand is now of a different stead compared to then, we have pegged our RNAV base-case value of $5.05 to a 40 per cent discount, implying end-2009 fair value of $3.05.
Risks include further tightening of credit markets and more macroeconomic dampeners. Catalysts include more government measures to prop up domestic residential property markets and further timely divestments or acquisitions.
ComfortDelGro ('buy', TP: $1.63): Plunging crude oil prices will stimulate earnings.
Sembcorp Marine ('buy', TP: $2.49): Sustainable amid challenging conditions. Our earnings forecasts have factored in slowing new order momentum.
Singapore Press Holdings ('buy', TP: $4.35): Over the years, SPH has successfully diversified its business, moving into magazines, property and the Internet. Recurring income in the current two financial years should be aided by the property segment, thanks to high rentals for its flagship Paragon mall as well as its sold-out Sky@eleven project.
StarHub ('buy', TP: $2.68): There have been some concerns over its gearing, but a closer look at its financials would bring comfort to investors. Net gearing for the company stood at 7.6 times in Q3 2008, which ranks it among the highest in the market.
However, there was a capital repayment of $1.1 billion, which resulted in shareholders' equity shrinking to a mere $103 million. If not for this, the net gearing would have only been 0.7 times - a decent figure, given that StarHub paid out dividends of $621 million in 2005-07, and declared another $230 million this year. The cash it generates is also more than sufficient to repay its debts.
ST Engineering ('buy', TP: $2.83): Robust financials, good cash flows from operations, long-term prospects still bullish, and orders remain strong.
United Overseas Bank ('buy', TP: $16.00): Conservative loan expansion over the past four years will keep non-performing loans contained. Our earnings forecasts have factored in huge loan provisions. Interest income should be cushioned by its relatively high loan-to-deposit ratio.
Other mid-cap stocks that also deserve attention are:
Ascendas Reit ('buy', TP: $1.75): Its present price presents a good entry point for investors to buy into a strong sponsor-backed industrial Reit with quality assets and an established track record, as well as stable income backed by long lease tenures.
China Milk ('buy', TP: $0.52): The company is able to generate consistent free cash flows over the years. We believe China Milk can ride through this crisis well.
Indofood Agri Resources ('buy', TP: $1.12): Indofood Agri has the ability to obtain refinancing for its short-term debt, despite the current credit tightening environment. While lower crude palm oil prices will affect earnings, this is partially mitigated by Indofood Agri's growing cooking oil & fats segment.
Li Heng Chemical Fibre ('buy', TP: $0.685): With capital expenses fully budgeted for, and at least another one billion yuan ($224 million) worth of operating cash inflow from H2 2008 to FY2009, the group should be able to withstand any further repercussions from the credit crisis and a slowdown in its business environment.
Raffles Medical Group ('buy', TP: $0.77): Strong operating cash flows should help it face challenges ahead. It has a healthy patient load, a diversified patient base, and a healthy balance sheet.
Venture Corp ('buy', TP: $7.40): Venture has managed to generate quarterly revenue and core operating profit exceeding $900 million and $66 million, respectively, since Q1 2007. While the prospects for Venture may have taken a step back in recent times due to the global economic downturn, we do believe that the present selldown in its share price appears over-extended.
-Research Report by DMG & Partners Securities (19 Nov)
TARGETING survivors: Some corporates may not have banks' support through this rough patch. The market remains concerned about the impact of global economic deterioration on corporate earnings.
Investors are closely scrutinising companies that have overstretched via massive borrowings to fund their growth, or have yet to generate sufficient operating cash flow, as these corporates are at the highest risk of breaching bank covenants if business conditions worsen further.
On the other hand, there are corporates whose balance sheets are strong. Even with the deterioration in business conditions, banks will continue to support these corporates for their working capital and capital expenditure needs.
These are the companies that are seen to survive this downturn. When economic conditions eventually improve, these companies could return to similar levels of profit or even exceed their previous peak profit levels.
Over the past few weeks, we have reviewed the financial forecasts and TPs for all the stocks under our coverage. With the cuts in TPs, we now arrive at a fair Straits Times Index (STI) target of 2,080 over the next 12 months.
However, in the short term, we see further weakness which could bring the STI to as low as 0.95 times P/B, or a 1,560 level. With the downside of about 10 per cent from the current STI level and difficulty in pinpointing the exact bottom, we recommend investors to start nibbling at stocks that will survive this crisis.
We have identified the following big-cap stocks which we believe will ride through the crisis and emerge stronger:
CapitaLand ('buy', TP: $3.05): At current levels, CapitaLand is trading at a 24.4 per cent discount to its end-Q3 2008 NAV of $3.60. During past crises, CapitaLand has been trading at 40-60 per cent discount to NAV. Taking the view that CapitaLand is now of a different stead compared to then, we have pegged our RNAV base-case value of $5.05 to a 40 per cent discount, implying end-2009 fair value of $3.05.
Risks include further tightening of credit markets and more macroeconomic dampeners. Catalysts include more government measures to prop up domestic residential property markets and further timely divestments or acquisitions.
ComfortDelGro ('buy', TP: $1.63): Plunging crude oil prices will stimulate earnings.
Sembcorp Marine ('buy', TP: $2.49): Sustainable amid challenging conditions. Our earnings forecasts have factored in slowing new order momentum.
Singapore Press Holdings ('buy', TP: $4.35): Over the years, SPH has successfully diversified its business, moving into magazines, property and the Internet. Recurring income in the current two financial years should be aided by the property segment, thanks to high rentals for its flagship Paragon mall as well as its sold-out Sky@eleven project.
StarHub ('buy', TP: $2.68): There have been some concerns over its gearing, but a closer look at its financials would bring comfort to investors. Net gearing for the company stood at 7.6 times in Q3 2008, which ranks it among the highest in the market.
However, there was a capital repayment of $1.1 billion, which resulted in shareholders' equity shrinking to a mere $103 million. If not for this, the net gearing would have only been 0.7 times - a decent figure, given that StarHub paid out dividends of $621 million in 2005-07, and declared another $230 million this year. The cash it generates is also more than sufficient to repay its debts.
ST Engineering ('buy', TP: $2.83): Robust financials, good cash flows from operations, long-term prospects still bullish, and orders remain strong.
United Overseas Bank ('buy', TP: $16.00): Conservative loan expansion over the past four years will keep non-performing loans contained. Our earnings forecasts have factored in huge loan provisions. Interest income should be cushioned by its relatively high loan-to-deposit ratio.
Other mid-cap stocks that also deserve attention are:
Ascendas Reit ('buy', TP: $1.75): Its present price presents a good entry point for investors to buy into a strong sponsor-backed industrial Reit with quality assets and an established track record, as well as stable income backed by long lease tenures.
China Milk ('buy', TP: $0.52): The company is able to generate consistent free cash flows over the years. We believe China Milk can ride through this crisis well.
Indofood Agri Resources ('buy', TP: $1.12): Indofood Agri has the ability to obtain refinancing for its short-term debt, despite the current credit tightening environment. While lower crude palm oil prices will affect earnings, this is partially mitigated by Indofood Agri's growing cooking oil & fats segment.
Li Heng Chemical Fibre ('buy', TP: $0.685): With capital expenses fully budgeted for, and at least another one billion yuan ($224 million) worth of operating cash inflow from H2 2008 to FY2009, the group should be able to withstand any further repercussions from the credit crisis and a slowdown in its business environment.
Raffles Medical Group ('buy', TP: $0.77): Strong operating cash flows should help it face challenges ahead. It has a healthy patient load, a diversified patient base, and a healthy balance sheet.
Venture Corp ('buy', TP: $7.40): Venture has managed to generate quarterly revenue and core operating profit exceeding $900 million and $66 million, respectively, since Q1 2007. While the prospects for Venture may have taken a step back in recent times due to the global economic downturn, we do believe that the present selldown in its share price appears over-extended.
-Research Report by DMG & Partners Securities (19 Nov)
Labels:
China Milk,
IndoAgri,
Research Reports,
SembMarine,
STIndex
Wednesday, October 1, 2008
China Milk says raw milk samples safe
by LYNETTE KHOO (30 Sept)
China Milk said its raw milk samples were tested and confirmed by a government laboratory in Daqing to be free from any trace of melamine.
The group had sent its raw milk samples on Sept 26 to Daqing Bureau of Products Quality Supervision and Inspection a government laboratory accredited by the Heilongjiang Bureau of Quality and Technical Supervision.
The raw milk samples were also confirmed by the independent laboratory as compliant with the standards laid down by the national standards for the qualifications of raw and fresh milk, GB6914-1986.
-Editorial Report by LYNETTE KHOO (30 Sept)
China Milk said its raw milk samples were tested and confirmed by a government laboratory in Daqing to be free from any trace of melamine.
The group had sent its raw milk samples on Sept 26 to Daqing Bureau of Products Quality Supervision and Inspection a government laboratory accredited by the Heilongjiang Bureau of Quality and Technical Supervision.
The raw milk samples were also confirmed by the independent laboratory as compliant with the standards laid down by the national standards for the qualifications of raw and fresh milk, GB6914-1986.
-Editorial Report by LYNETTE KHOO (30 Sept)
Thursday, July 24, 2008
China Milk Research Report
by DMG & PARTNERS (24 July)
CHINA Milk is currently benefiting from China's dairy consumption boom.
According to United Nations statistics, total dairy consumption in China reached 19 million tonnes in 2006. By 2008, it is expected to surpass 25 million tonnes.
This growth would peg China's total market size ahead of major European dairy markets such as France and Germany.
We believe that China Milk, which is currently the largest producer of pedigree bull semen, cow embryos, and raw milk in China, is going to benefit from these trends. We initiate coverage on China Milk with a target price of S$0.99.
The rationale for China Milk lies within its outlook, strategy, and plans going forward.
Our justification is simple.
Firstly, the company is in a strong net cash position of 726.5 million yuan (0.98 yuan per share) to expand its business even further.
With a total herd size of 18,390 as at end-March, the company is looking to double its current size by FY2010 through purchasing more Canadian and Australian Holsteins. The cost of one Canadian Holstein is nearly double that of an Australian Holstein's 28,000 yuan.
Currently China has an import ban on Canadian Holsteins due to the mad cow disease. We believe the government may lift the ban by FY2010.
On top of doubling its herd size, the company is expanding its business downstream through milk processing.
This will further strengthen China Milk as a major player in the dairy business. We expect further growth earnings in FY2009, fuelled by the increasing demand for dairy products in China.
Long-term outlook looks attractive with the group planning to increase its herd size which will enable them to produce more bull semen, cow embryo, raw milk, and processed milk.
We conservatively estimate earnings to grow 15 per cent to 552.5 million yuan in FY2009, and 11.2 per cent to 614.5 million yuan in FY2010.
We have a price target based on a forward FY2010 PE of 6 which is a FY2010 PE-to-growth ratio of 0.5. This implies an upside of 42 per cent from current levels. China Milk is currently trading at a FY2009 PE of 4.7 and a forward FY2010 PE of 4.2, which is considerably lower compared to its regional peers' FY2009 PE of 20.2.
-Research Report by DMG & PARTNERS (24 July)
CHINA Milk is currently benefiting from China's dairy consumption boom.
According to United Nations statistics, total dairy consumption in China reached 19 million tonnes in 2006. By 2008, it is expected to surpass 25 million tonnes.
This growth would peg China's total market size ahead of major European dairy markets such as France and Germany.
We believe that China Milk, which is currently the largest producer of pedigree bull semen, cow embryos, and raw milk in China, is going to benefit from these trends. We initiate coverage on China Milk with a target price of S$0.99.
The rationale for China Milk lies within its outlook, strategy, and plans going forward.
Our justification is simple.
Firstly, the company is in a strong net cash position of 726.5 million yuan (0.98 yuan per share) to expand its business even further.
With a total herd size of 18,390 as at end-March, the company is looking to double its current size by FY2010 through purchasing more Canadian and Australian Holsteins. The cost of one Canadian Holstein is nearly double that of an Australian Holstein's 28,000 yuan.
Currently China has an import ban on Canadian Holsteins due to the mad cow disease. We believe the government may lift the ban by FY2010.
On top of doubling its herd size, the company is expanding its business downstream through milk processing.
This will further strengthen China Milk as a major player in the dairy business. We expect further growth earnings in FY2009, fuelled by the increasing demand for dairy products in China.
Long-term outlook looks attractive with the group planning to increase its herd size which will enable them to produce more bull semen, cow embryo, raw milk, and processed milk.
We conservatively estimate earnings to grow 15 per cent to 552.5 million yuan in FY2009, and 11.2 per cent to 614.5 million yuan in FY2010.
We have a price target based on a forward FY2010 PE of 6 which is a FY2010 PE-to-growth ratio of 0.5. This implies an upside of 42 per cent from current levels. China Milk is currently trading at a FY2009 PE of 4.7 and a forward FY2010 PE of 4.2, which is considerably lower compared to its regional peers' FY2009 PE of 20.2.
-Research Report by DMG & PARTNERS (24 July)
Saturday, May 10, 2008
China Milk 090508
The break above the 0.820 resistance (red --) was short-lived, as China Milk tumbled back down to earth, even breaking the uptrend support (upp blue).

China Milk is now trading quite close to the long term downtrend support (mid pink). If that support breaks, we might see China Milk testing the 0.740 support (red ...).
If China Milk can trade within the uptrend channel (blue), and above the uptrend support (low blue), there's a chance it might test the 0.820 resistance (red --) again next week.
For monday :
Support @ 0.790 (low blue), 0.775 (mid pink), 0.753 (low pink), 0.740 (red ...)
Resistance @ 0.800 (mid blue), 0.820 (upp blue, red --), 0.835 (red), 0.840 (4 mar, 9 may peak)
Good Luck !!
China Milk is now trading quite close to the long term downtrend support (mid pink). If that support breaks, we might see China Milk testing the 0.740 support (red ...).
If China Milk can trade within the uptrend channel (blue), and above the uptrend support (low blue), there's a chance it might test the 0.820 resistance (red --) again next week.
For monday :
Support @ 0.790 (low blue), 0.775 (mid pink), 0.753 (low pink), 0.740 (red ...)
Resistance @ 0.800 (mid blue), 0.820 (upp blue, red --), 0.835 (red), 0.840 (4 mar, 9 may peak)
Good Luck !!
Monday, April 14, 2008
China Milk 140408
There wasn't enough follow through buying for China Milk today, closing just on the downtrend resistance (upp red --).

If China Milk cannot open above the uptrend support (low blue), then we might see it testing the 0.680 support (blue --), or maybe even the 0.650 support (blue ...)
For tomorrow :
Support @ 0.6977 (upp red --), 0.680 (blue --), 0.650 (blue ...), 0.643 (low red)
Resistance @ 0.715 (low blue), 0.740 (red ...), 0.767 (upp blue), 0.780 (upp red)
Good Luck !!
If China Milk cannot open above the uptrend support (low blue), then we might see it testing the 0.680 support (blue --), or maybe even the 0.650 support (blue ...)
For tomorrow :
Support @ 0.6977 (upp red --), 0.680 (blue --), 0.650 (blue ...), 0.643 (low red)
Resistance @ 0.715 (low blue), 0.740 (red ...), 0.767 (upp blue), 0.780 (upp red)
Good Luck !!
Saturday, April 12, 2008
China Milk 110408
China Milk broke the long term resistance (mid red) and downtrend resistance (red --). Today is also the second time China Milk tested the 0.740 resistance (red ...). The 1st time being on 8 apr.

If China Milk opens above the two resistances (mid red, red --) on monday, there's a high chance it might break the 0.760 resistance (red ...).
Watch for volume for confirmation of a breakout.
For monday :
Support @ 0.7113 (mid red), 0.706 (upp red --), 0.700 (low blue), 0.650 (low red, low red --)
Resistance @ 0.740 (red ...), 0.756 (upp blue), 0.782 (upp red)
Good Luck !!
If China Milk opens above the two resistances (mid red, red --) on monday, there's a high chance it might break the 0.760 resistance (red ...).
Watch for volume for confirmation of a breakout.
For monday :
Support @ 0.7113 (mid red), 0.706 (upp red --), 0.700 (low blue), 0.650 (low red, low red --)
Resistance @ 0.740 (red ...), 0.756 (upp blue), 0.782 (upp red)
Good Luck !!
Subscribe to:
Posts (Atom)
